Renaissance Technologies’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.46M | Sell |
428,000
-196,700
| -31% | -$1.59M | ﹤0.01% | 1756 |
|
|
2025
Q1 | $5.23M | Sell |
624,700
-61,800
| -9% | -$518K | 0.01% | 1405 |
|
|
2024
Q4 | $5.44M | Sell |
686,500
-69,100
| -9% | -$547K | 0.01% | 1403 |
|
|
2024
Q3 | $6.29M | Buy |
755,600
+72,900
| +11% | +$607K | 0.01% | 1300 |
|
|
2024
Q2 | $4.34M | Buy |
682,700
+149,970
| +28% | +$952K | 0.01% | 1402 |
|
|
2024
Q1 | $3.23M | Buy |
532,730
+324,930
| +156% | +$1.97M | 0.01% | 1718 |
|
|
2023
Q4 | $1.26M | Buy |
207,800
+93,700
| +82% | +$569K | ﹤0.01% | 2249 |
|
|
2023
Q3 | $482K | Buy |
+114,100
| New | +$482K | ﹤0.01% | 2717 |
|
|
2023
Q1 | – | Sell |
-76,400
| Closed | -$152K | – | 3946 |
|
|
2022
Q4 | $152K | Sell |
76,400
-65,500
| -46% | -$130K | ﹤0.01% | 3500 |
|
|
2022
Q3 | $287K | Sell |
141,900
-30,500
| -18% | -$61.7K | ﹤0.01% | 3229 |
|
|
2022
Q2 | $548K | Buy |
172,400
+103,800
| +151% | +$330K | ﹤0.01% | 3110 |
|
|
2022
Q1 | $286K | Buy |
+68,600
| New | +$286K | ﹤0.01% | 3487 |
|
|
2021
Q2 | – | Sell |
-448,660
| Closed | -$3.02M | – | 3428 |
|
|
2021
Q1 | $3.02M | Buy |
448,660
+276,111
| +160% | +$1.86M | ﹤0.01% | 1962 |
|
|
2020
Q4 | $789K | Buy |
+172,549
| New | +$789K | ﹤0.01% | 2620 |
|
|
2019
Q3 | – | Sell |
-71,700
| Closed | -$514K | – | 3409 |
|
|
2019
Q2 | $514K | Sell |
71,700
-315,700
| -81% | -$2.26M | ﹤0.01% | 2983 |
|
|
2019
Q1 | $5.49M | Sell |
387,400
-566,300
| -59% | -$8.02M | 0.01% | 1748 |
|
|
2018
Q4 | $12.9M | Buy |
953,700
+573,000
| +151% | +$7.75M | 0.01% | 1160 |
|
|
2018
Q3 | $8.45M | Buy |
+380,700
| New | +$8.45M | 0.01% | 1463 |
|